RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000025.xml
Horm Metab Res 2009; 41(12): 909
DOI: 10.1055/s-0029-1243513
DOI: 10.1055/s-0029-1243513
Erratum
© Georg Thieme Verlag KG Stuttgart · New York
Erratum
Weitere Informationen
Publikationsverlauf
Publikationsdatum:
04. Dezember 2009 (online)
Foley JE, Sreenan S. Efficacy and Safety Comparison Between the DPP-4 Inhibitor Vildagliptin and the Sulfonylurea Gliclazide After Two Years of Monotherapy in Drug-naïve Patients with Type 2 Diabetes. Horm Metab Res 2009; 41: 905–909
In the original article Figure 2 was incorrect. In the line graph, the baseline data (at week 0) for HbA1c were missing. The corrected figure is provided below. This mistake does not affect the remaining content of the article.
This article is an erratum to 905 in: Journal of HMR, Issue 12, 2009 .